New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
11:55 EDTRIGL, ODP, TMO, PPHM, FEHigh option volume stocks: FE TMO RIGL PPHM ODP
News For FE;TMO;RIGL;PPHM;ODP From The Last 14 Days
Check below for free stories on FE;TMO;RIGL;PPHM;ODP the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
07:46 EDTRIGLRigel Pharmaceuticals management to meet with Leerink
Subscribe for More Information
07:37 EDTPPHMPeregrine announces investigator-sponsored combination trial with Bristol-Myers
Peregrine Pharmaceuticals (PPHM) announced the opening of an investigator-sponsored trial, or IST, of its investigational immunotherapy bavituximab in combination with Bristol-Myers Squibb's (BMY) ipilimumab, for the treatment of advanced melanoma. Bavituximab is an upstream immune checkpoint inhibitor that targets phosphatidylserine, or PS, a highly immunosuppressive molecule exposed on cells that line tumor blood vessels and tumor cells. Preclinical data in a model of melanoma demonstrate that the combination of a bavituximab equivalent and ipilimumab yield enhanced anti-tumor activity compared to ipilimumab alone. The trial is being conducted at the University of Texas Southwestern Medical Center, Dallas, and led by Arthur E. Frankel, M.D., Associate Professor of Internal Medicine at the Simmons Comprehensive Cancer Center. Bavituximab, Peregrine's lead immuno-oncology candidate, is being evaluated in second-line non-small cell lung cancer, as part of the SUNRISE pivotal Phase III clinical trial.
06:09 EDTTMOThermo Fisher reports Q1 Life Sciences Solutions segment revenue $836M
Subscribe for More Information
06:08 EDTTMOThermo Fisher raises FY14 adjusted EPS to $6.80-$6.95 from $6.70-$6.90
Subscribe for More Information
06:07 EDTTMOThermo Fisher is 'confident' it will deliver outlined synergy targets
06:02 EDTTMOThermo Fisher reports Q1 adjusted EPS $1.53, consensus $1.40
Reports Q1 revenue $3.90B, consensus $3.79B
05:55 EDTODPStocks with implied volatility movement; LAMR ODP
Subscribe for More Information
April 22, 2014
15:32 EDTTMONotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Procter & Gamble (PG), consensus $1.02; Boeing (BA), consensus $1.56; Biogen Idec (BIIB), consensus $2.56; Dow Chemical (DOW), consensus 71c; EMC Corporation (EMC), consensus 35c; Thermo Fisher (TMO), consensus $1.40; Praxair (PX), consensus $1.51; General Dynamics (GD), consensus $1.64; Johnson Controls (JCI), consensus 65c; Norfolk Southern (NSC), consensus $1.15; Reynolds American (RAI), consensus 74c; Delta Air Lines (DAL), consensus 29c; Northrop Grumman (NOC), consensus $2.15; Air Products & Chemicals (APD), consensus $1.35; TD Ameritrade (AMTD), consensus 34c; Ingersoll-Rand (IR), consensus 26c; Dr Pepper Snapple (DPS), consensus 59c; Polaris Industries (PII), consensus $1.16; Ryder System (R), consensus 87c.
April 21, 2014
08:03 EDTFEFirstEnergy's Beaver Valley Unit 2 shut down for maintenance
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use